Fibrolamellar Cancer Foundation is ranked among disease & disorders organizations in Greenwich, CT, with an America's Best Score of 70 out of 100, based on its 2024 Form 990.
Fibrolamellar Cancer Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G193). Contributions are tax-deductible.
20 Horseneck Lane 2Nd Floor, Greenwich, CT 06830-6327
Among the 3 scored disease & disorders organizations in Greenwich, Fibrolamellar Cancer Foundation holds 29.1 months of operating reserves (peer median 31.4 months), runs a typical yearly surplus of 19.7% (peers: surplus of 1.2%), and has grown spending 5.5% a year (peers: grown spending 5.5% a year).
In fiscal year 2024 it reported $3,413,883 in revenue and $2,853,234 in expenses, with contributions making up 90.5% of revenue.
Fibrolamellar Cancer Foundation,(the "foundation") was established to raise awareness and research funds for fibrolamellar carcinoma, a rare form of liver cancer that is primarily seen in teens and young adults. Currently, there are no viable treatment options other than liver resection surgery. Our mission is to find a cure and reliable treatment options for those diagnosed with this rare disease as well as enhance communications among healthcare professionals and patients.
Main program · fiscal year 2024
Grants to research organizations for fibrolamellar carcinoma studies.$2,338,262 spent
Where each dollar went · fiscal year 2024
Of every dollar it spent, 82¢ went to programs, 17¢ to management and 1¢ to fundraising.
Programs $2,338,262
Management $485,364
Fundraising $29,608
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
82%
Meets
Compared with Greenwich peers
Measure
This organization
Peer median
Operating reserves
29.1 mo
31.4 mo
Typical margin
+19.7%
+1.2%
Spending growth
+5.5% / yr
+5.5% / yr
Debt load
32.3%
0.0%
Peers: the 3 Greenwich disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$3,413,883Fiscal year 2024
Expenses$2,853,234Fiscal year 2024
Total assets$10,229,754Fiscal year 2024
Total liabilities$3,307,756Fiscal year 2024
Fiscal year ending December2024
Revenue$3,413,883
Expenses$2,853,234
Net income$560,649
Net assets$6,921,998
Notable sources of revenue
Percent of total revenue
Contributions
$3,088,534
90.5%
Program services
$0
0.0%
Investment income
$325,349
9.5%
Other (net)
$0
0.0%
Assets / debt
Total assets
$10,229,754
Total liabilities
$3,307,756
Net assets
$6,921,998
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$2,960,135
Expenses$5,485,040
Net income−$2,524,905
Net assets$6,401,759
Notable sources of revenue
Percent of total revenue
Contributions
$2,241,100
75.7%
Program services
$0
0.0%
Investment income
$138,665
4.7%
Other (net)
$580,370
19.6%
Assets / debt
Total assets
$10,499,605
Total liabilities
$4,097,846
Net assets
$6,401,759
Compensation
Officers and key employees
$273,188
Share of expenses
5.0%
Fiscal year ending December2022
Revenue$6,076,635
Expenses$2,563,688
Net income$3,512,947
Net assets$9,273,502
Notable sources of revenue
Percent of total revenue
Contributions
$6,073,580
99.9%
Program services
$0
0.0%
Investment income
$3,055
0.1%
Other (net)
$0
0.0%
Assets / debt
Total assets
$10,981,422
Total liabilities
$1,707,920
Net assets
$9,273,502
Compensation
Officers and key employees
$200,000
Share of expenses
7.8%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?